Federal health agencies, including the FDA, CMS, and HHS, are aligning oversight frameworks for artificial intelligence in healthcare, covering diagnostics, treatment planning, and insurance approvals ...
Recent research and clinical updates highlight how GLP-1 receptor agonists are transforming diabetes and obesity care, with expanding uses from adolescents with type 2 diabetes to off-label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results